Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - george+sutphin
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel Multi-Omics Aging Clock
A multi-omics clock analyzes multiple layers of omics data with machine learning to predict remaining lifespan of mammals, particularly for animal model studies. Large omics data sets may be used from combinations of genomics, proteomics, lipids, etc. available from blood or other simple sample collection. This tool can robustly capture changes...
Published: 3/12/2024
|
Inventor(s):
George Sutphin
,
Samuel Freitas
,
Megha Padi
,
Chen Chen
Keywords(s):
Category(s):
Technology Classifications > Life Sciences > Biomarkers
,
Technology Classifications > Research Tools > Animal Models
,
Technology Classifications > Research Tools > Screening assays
,
Technology Classifications > Research Tools > Simulators and Modeling Tools
Novel Antibiotic Drug Combination Including an Anti-Inflammatory Metabolite
This technology involves a combination of a metabolite, 3-hydroxyanthanilic acid (3HAA) with a compound that alters cellular iron homeostasis (e.g. an iron chelator or an iron supplement) that produces synergistic antibiotic interaction. 3HAA sensitizes bacteria to changes in iron availability (both increasing iron media content through supplementation...
Published: 3/12/2024
|
Inventor(s):
George Sutphin
,
Luis Espejo
Keywords(s):
Category(s):
Technology Classifications > Healthcare Portfolios > Infectious Diseases
,
Technology Classifications > Healthcare Portfolios > Immunology, Autoimmune & Inflammation
,
Technology Classifications > Life Sciences > Small Molecules
,
Technology Classifications > Life Sciences > Therapeutics
Anti-Aging via HAAO Blockers
This invention relates to methods of preventing or treating age-related diseases comprising targeting the kynurenine pathway by blocking, reducing expression, or reducing activity of 3-hydroxyanthranilic acid dioxygenase (HAAO), and or increasing the bioavailability of 3-hydroxyanthranilic acid (3HAA). Background: Human diseases are characterized...
Published: 3/12/2024
|
Inventor(s):
George Sutphin
Keywords(s):
Category(s):
Technology Classifications > Healthcare Portfolios
,
Technology Classifications > Life Sciences